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To the Editor: I read the study by Ahmad et al.1 with great
interest. The authors should be commended for their effort
to determine if the use of new biocompatible peritoneal
dialysis solutions can reduce peritonitis rate. However,
demographic details of the patients in the two groups
(‘standard lactate’ group vs ‘bicarbonate/lactate’) were not
provided. If biocompatible solutions were introduced in 2003
with data collected for all patients on peritoneal dialysis (PD)
between 2002–2005, were the authors comparing predomi-
nantly prevalent patients using standard lactate with incident
patients starting on bicarbonate/lactate? If so, it is likely that
patients using standard lactate solutions had longer dialysis
follow-up. The authors themselves have documented the
importance of dialysis vintage on the outcome of PD
peritonitis,2 while the Australia and New Zealand dialysis
and transplant Registry (ANZDATA) showed this was an
important risk factor for developing peritonitis.3 We also
confirmed the effect of dialysis vintage on peritonitis rate; of
patients that started PD between January 1, 2001 and
December 31, 2002, PD peritonitis rate increased with time
on dialysis particularly after the first 12 months of starting
PD (Table 1). Of course, it was not possible to determine why
peritonitis risk increases with dialysis vintage; it could be
related to loss of residual kidney function, technique ‘burn
out’, colonization of PD catheters or the acquisition of ‘bad
habits’ over time.
Evidence that the use of biocompatible dialysis can reduce
peritonitis rate would be very exciting but without further
details it may be premature to use these more expensive
solutions in the expectation that peritonitis rate will decline.
Results of prospective randomized studies comparing the
new biocompatible PD solutions with standard solutions are
eagerly awaited.
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To the Editor: The editor is to be commended for his clear
position on Plagiarism.1 It is unfortunate that such a subject
needs to be raised in as prestigious a journal as Kidney
International. To quote the editor ‘I submit that the best
writers always knowingly referred to their predecessors’.
There are many excellent examples demonstrating this
point dating back several thousand years in the Hebrew legal
tradition. The Mishna, codified 1800 years ago, and the
Babylonian Talmud, codified 1500 years ago, continuously
quote the source for many statements on each page. To this
point, a particular story in the Talmud would seem of interest
– ‘Rav Ashi said to Mar Kashisha: Have I not said to you, do
not change names of people when you attribute a ruling’. The
Talmud relates this discussion to demonstrate how careful the
Rabbis were in preserving the exact chain of the rabbinical
discussion and that all their words were a clear tradition from
reliable sources.2 This same concept can be traced back to the
Book of Esther3 read this coming week of Purim, where
Mordecai hears that two guards plan on killing the king
Ahasuerus. Mordecai tells his relative Queen Esther and she
‘‘reported it to the king in Mordecai’s name.’’ The date of the
Book of Esther is over 2500 years ago.
Thus, the tradition of acknowledging the original source
clearly dates back far into history. As the editor indicated, it is
a tradition at least as important today in Science and
Nephrology as it was in earlier generations.
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Table 1 | Impact of dialysis vintage on PD peritonitis rate on a
cohort of incident PD patients
Months Rate Patient months at risk
0–6 1 in 26 851
6–12 1 in 26 737
12–18 1 in 16 624
18–24 1 in 18 516
24–36 1 in 22 302
36–42 1 in 19 181
PD, peritoneal dialysis.
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